On November 29, 2023, the Board of Directors of Calidi Biotherapeutics, Inc. received the resignation of Mr. Alfonso Zulueta as a director, including his position on audit committee of the Board, effective immediately. Mr. Zulueta's resignation is for personal reasons and not due to any disagreement with the Company's management team or the Company's Board on any matter relating to the operations, policies or practices of the Company or any issues regarding the Company's accounting policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2258 USD | +1.62% | -0.40% | -85.05% |
04-16 | Calidi Biotherapeutics Prices $6.1 Million Offering | MT |
03-21 | H.C. Wainwright Lowers Price Target on Calidi Biotherapeutics to $2 From $11, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.05% | 10.88M | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- CLDI Stock
- News Calidi Biotherapeutics, Inc.
- Calidi Biotherapeutics, Inc. Announces the Resignation of Alfonso Zulueta as A Director, Including His Position on Audit Committee of the Board